Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)
China flag China · Delayed Price · Currency is CNY
26.52
-0.27 (-1.01%)
Mar 11, 2026, 11:29 AM CST

Nanjing Well Pharmaceutical Group Company Description

Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical excipients and synthetic lubricating base oils to the pharmaceutical companies in China.

It is involved in the bio-based material manufacturing, sales, and technology development; technical development and consulting; bio-based material technology research and development; biochemical product technology research and development; food and food additive production and sales; and research and development of new material technologies, as well as provides technical services; and manufactures and sells electronic materials.

The company also exports its products to Europe, the United States, Southeast Asia, and internationally.

The company was formerly known as Nanjing Well Pharmaceutical Co.,Ltd. and changed its name to Nanjing Well Pharmaceutical Group Co.,Ltd. in April 2020.

Nanjing Well Pharmaceutical Group Co.,Ltd. was founded in 2000 and is based in Nanjing, China.

Nanjing Well Pharmaceutical Group Co.,Ltd.
Country China
Founded 2000
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 711
CEO Renrong Wu

Contact Details

Address:
Building 5,No. 64 Suning Avenue
Nanjing, 210042
China
Phone 86 25 8317 2922
Website well-js.com

Stock Details

Ticker Symbol 603351
Exchange Shanghai Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100003JD4
SIC Code 2990

Key Executives

Name Position
Renrong Wu Chairman and Chief Executive Officer
Qunsong Tang Vice President, Secretary of the Board of Directors and Chief Financial Officer
Zhengsong Gao Director, Vice President and Chief Engineer
Xinguo Chen Director and Vice President
Jianguo Zou Vice President
Yi Yang Accounting Supervisor